CA
NZ
UK
AU
IND
US
Snowflake Inc. (NYSE: SNOW) reported a strongEarningsperformance for the quarter ended June 30, 2026, achieving an EPS of $0.39, which exceeded analyst expectations of $0.32. Investors are likely encouraged by these results, which underline the company's strategic positioning in a rapidly evolving tech environment. …
The amendment preserves the core provisions of the original 2025 arrangement while introducing Maxim Group LLC as an additional sales agent. This adjustment expands the company’s financing flexibility beyond the earlier $8 million limit, providing a broader avenue forCapitalwithout a conventionalEquityoffering. The enhancedFacilityallows the …
NBCUniversal's newly announced collaboration with YouTube is set to reshape the environment of the streaming wars as the industry pivots toward content aggregation. This partnership allows NBCUniversal to utilize YouTube's substantial user base and advanced technology to deliver its vast array of content more …
Microsoft's stock jumped 15.5%, marking its best day since 2008, and drove a significant rebound in U.S. markets. The S&P 500 gained 1.7%, while the Dow Jones Industrial Average surged 613 points, or 1.2%. Investors responded positively to Microsoft’s stronger-than-expected quarterly profits and particularly …
Elanco Animal Health (NYSE:ELAN) closed at $26.37, down nine cents, or 0.34%, on volume of about 5.2 million shares. That is a shrug of a session, and an unusually calm one, given what happens next. The company reports second-quarter results on Wednesday, 5 August, …
Apple's outgoing CEO Tim Cook characterized the company's hybridArtificial Intelligence (AI)strategy as a key competitive weapon, highlighting its significance as Apple prepares to monetarily integrate AI capabilities into iCloud services. This strategic positioning ahead of the upcoming Siri AI launch could enhance Apple's competitive …
Lilly (NYSE:LLY) reports second-quarter 2026 results on August 5 and hosts a conference call at 10 a.m. Eastern. Investors already know roughly what the injectables will do. What they do not know is whether the company's oral GLP-1, Foundayo (orforglipron), is a slow starter …
Labor Battle Ignites Over AV Deployment
A growing perception suggests the United States is on the verge of losing its technological superiority in artificial intelligence to China. This shift comes amid increased scrutiny of U.S. capabilities in formulating a strategy that preserves its leading position. The implications for various sectors, …
Exelixis (Nasdaq:EXEL) closed at $53.03 at last closing, down $2.94 or 5.25%, on roughly 3.0 million shares against a recent daily average nearer two million. The size of the fall matches the move flagged in early commentary. Its cause does not match the usual …
Please wait processing your request...